跳至主要内容
临床试验/NCT06137014
NCT06137014招募中1 期

Reduction of Severity and Duration of Pediatric Gastroenteritis Through Amino Acid Fortified Oral Rehydration Therapy

Paul A Breslin1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2024年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
72
试验地点
1
主要终点
Daily Stool Frequency

研究概览

简要总结

The goal of this clinical trial is to compare amino acid-fortified oral rehydration therapy (ORT) to the standard of care ORT in pediatric patients with acute gastroenteritis (AGE). The main questions it aims to answer are:

  • can amino acid-fortified ORT reduce the duration and severity of AGE compared to standard of care ORT?
  • can amino acid-fortified ORT increase the secretion of antimicrobial peptides in the gastrointestinal tract compared to standard of care ORT?

Participants will be assigned to the experimental treatment (amino acid-fortified ORT) or the standard of care ORT and their disease severity, duration, and stool antimicrobial peptide content.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
6 Months 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 6 months and 5 years.
  • Experiencing mild to moderate acute gastroenteritis for less than two (2) days before admission to Pediatric Emergency Department.
  • Diarrhea presumed infectious

排除标准

  • Severe gastroenteritis with moderate to severe dehydration
  • Requiring inpatient care
  • Requiring antibiotics
  • Requiring IV rehydration
  • History of chronic diarrhea
  • Presenting with diarrhea for greater than 2 days prior to admission
  • Allergy to any of the ingredients in the study products
  • Inborn metabolic disorder of amino acids
  • Receives post-pyloric feedings

研究组 & 干预措施

Amino acid-fortified oral rehydration therapy

Experimental

Participants will consume the amino acid-fortified oral rehydration therapy (fORT) according to the World Health Organization (WHO) Treatment Plan A for ORT administration:

  • Child under 24 months: 50 to 100 ml ORT after each loose stool (approximately 500 ml daily)
  • Child from 2 to 10 years: 100 to 200 ml ORT after each loose stool (approximately 1000 ml daily)

干预措施: Fortified Oral Rehydration Therapy (Drug)

Standard of care oral rehydration therapy

Placebo Comparator

Participants will consume the standard of care oral rehydration therapy according to the WHO Treatment Plan A for ORT administration:

  • Child under 24 months: 50 to 100 ml after each loose stool (approximately 500 ml daily)
  • Child from 2 to 10 years: 100 to 200 ml after each loose stool (approximately 1000 ml daily)

干预措施: Standard of Care Oral Rehydration Therapy (Dietary Supplement)

结局指标

主要结局

Daily Stool Frequency

时间窗: Up to 14 days

Number of bowel movements (BMs) per day (count)

Daily Stool Mass

时间窗: Up to 14 days

Total mass of stool per day from measured BMs in grams

Duration of Diarrhea

时间窗: Up to 14 days

Duration of diarrhea in hours from onset until 3 formed stools in a row

次要结局

  • Consumption of Study Intervention(Up to 14 days)
  • Stool Human Beta-Defensin-2 Content(Up to 14 days)
  • Body Weight(Up to 14 days)
  • Stool Consistency(Up to 14 days)

研究者

发起方
Paul A Breslin
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Paul A Breslin

Professor of Nutritional Sciences

Rutgers, The State University of New Jersey

研究点 (1)

Loading locations...

相似试验